🚀 Amazon surpasses Walmart for the first time

In partnership with

Is it time to expand your portfolio?

• AI discovery for cities to call home

• Massive market of 30M U.S. relocations per year

• Founders with 6 exits & $100M+ ARR experience

Join the Raise

Read the Offering information carefully before investing. It contains details of the issuer’s business, risks, charges, expenses, and other information, which should be considered before investing. Obtain a Form C and Offering Memorandum at https://wefunder.com/lookyloo

Market Overview
Read time 1.4 minutes

Year To Date Performances:

1. Amazon is on track to surpass Walmart in quarterly revenue for the first time, with analysts projecting $187 billion in sales for Amazon compared to Walmart’s expected $180 billion. While Walmart still leads in annual revenue—forecasted at $681 billion for the year—Amazon’s rapid growth, fueled by its cloud division AWS and booming e-commerce, is narrowing the gap. If estimates hold, Amazon will hit $638 billion in annual revenue, marking its first time above $600 billion. Walmart has held the quarterly revenue crown since 2012, but Amazon’s momentum suggests a shifting retail landscape.

2. Peloton reported mixed Q2 results, with revenue beating estimates at $674 million (vs. $654 million expected) but a wider-than-expected loss of 24 cents per share (vs. 18 cents expected). The company slashed costs in key areas, driving adjusted EBITDA to $58.4 million—more than double analyst expectations. While hardware sales declined 21%, Peloton improved margins and saw strong holiday sales through Costco. Under new CEO Peter Stern, the company is prioritizing profitability over sales growth, forecasting weaker Q3 revenue but stronger-than-expected cash flow, with hopes of revenue stabilization by year-end. Shares surged 13% in response.

3. Eli Lilly reported mixed Q4 results, with earnings beating expectations at $5.32 per share (vs. $4.95 expected) but revenue slightly missing at $13.53 billion (vs. $13.57 billion expected), as lower realized prices for Mounjaro offset strong demand. The company reaffirmed its 2025 sales guidance of $58-61 billion and projected earnings of $22.05 to $23.55 per share. While Mounjaro and Zepbound fell short of forecasts for the second straight quarter, Eli Lilly expects to ramp up incretin drug production by 1.6 times in early 2025, signaling efforts to meet surging demand.

4. Headlines

   1. Yum Brands beat earnings expectations due to a surge in Taco Bell sales.

   2. Republicans have yet to pass a tax cut bill due to internal disagreements over the size of potential cuts, with some wanting as much as $2T in tax cuts over the next 10 years.

   _{* This is sponsored content.}

Are you looking to grow your business? Here is how I can help: 

📱Book a Strategy Call to get 1:1 feedback on your pitch, pitch deck and/or fundraising strategy. (If you need general startup advice, then reply to this email, and I’ll let you know if/how I can help.)

Diversified Crypto Exposure Without the Complexity – No wallets, just one trade.

DeFi Technologies (CBOE: DEFI OTC: DEFTF) is redefining crypto investing—offering broad exposure to 60+ cryptocurrencies in one stock. No wallets, no exchanges—just seamless access to the $3T digital asset market.

With $1B+ AUM and 133% YoY growth, DeFi Technologies bridges traditional finance and DeFi, providing regulated and diversified access to digital assets like Bitcoin and Solana.

Key Highlights:

✅ Most diversified crypto stock
✅ Potential Nasdaq listing underway
✅ Strong analyst ratings & institutional interest
✅ Buy directly in your brokerage account (CBOE: DEFI OTC: DEFTF)

Get ahead of the next wave of crypto adoption by traditional finance.

Invest today.

Onwards and Upwards,

Liam Gill